These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 19669860)

  • 21. Extracellular matrix made by bone marrow cells facilitates expansion of marrow-derived mesenchymal progenitor cells and prevents their differentiation into osteoblasts.
    Chen XD; Dusevich V; Feng JQ; Manolagas SC; Jilka RL
    J Bone Miner Res; 2007 Dec; 22(12):1943-56. PubMed ID: 17680726
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of primitive subpopulations of normal and leukemic cells present in the blood of patients with newly diagnosed as well as established chronic myeloid leukemia.
    Petzer AL; Eaves CJ; Lansdorp PM; Ponchio L; Barnett MJ; Eaves AC
    Blood; 1996 Sep; 88(6):2162-71. PubMed ID: 8822936
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long term maintenance of myeloid leukemic stem cells cultured with unrelated human mesenchymal stromal cells.
    Ito S; Barrett AJ; Dutra A; Pak E; Miner S; Keyvanfar K; Hensel NF; Rezvani K; Muranski P; Liu P; Larochelle A; Melenhorst JJ
    Stem Cell Res; 2015 Jan; 14(1):95-104. PubMed ID: 25535865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of the tyrosine kinase inhibitor AG957 and an Anti-Fas receptor antibody on CD34(+) chronic myelogenous leukemia progenitor cells.
    Carlo-Stella C; Regazzi E; Sammarelli G; Colla S; Garau D; Gazit A; Savoldo B; Cilloni D; Tabilio A; Levitzki A; Rizzoli V
    Blood; 1999 Jun; 93(11):3973-82. PubMed ID: 10339507
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mimicking the Acute Myeloid Leukemia Niche for Molecular Study and Drug Screening.
    Houshmand M; Soleimani M; Atashi A; Saglio G; Abdollahi M; Nikougoftar Zarif M
    Tissue Eng Part C Methods; 2017 Feb; 23(2):72-85. PubMed ID: 28007011
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection and characterization of primitive malignant and normal progenitors in patients with acute myelogenous leukemia using long-term coculture with supportive feeder layers and cytokines.
    Ailles LE; Gerhard B; Hogge DE
    Blood; 1997 Oct; 90(7):2555-64. PubMed ID: 9326221
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bestatin selectively suppresses the growth of leukemic stem/progenitor cells with BCR/ABL mRNA transcript in patients with chronic myelogeneous leukemia.
    Fujisaki T; Otsuka T; Gondo H; Okamura T; Niho Y; Ohhinata A; Abe F
    Int Immunopharmacol; 2003 Jun; 3(6):901-7. PubMed ID: 12781706
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional assessment of hematopoietic niche cells derived from human embryonic stem cells.
    Ferrell PI; Hexum MK; Kopher RA; Lepley MA; Gussiaas A; Kaufman DS
    Stem Cells Dev; 2014 Jun; 23(12):1355-63. PubMed ID: 24517837
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective expansion of primitive normal hematopoietic cells in cytokine-supplemented cultures of purified cells from patients with chronic myeloid leukemia.
    Petzer AL; Eaves CJ; Barnett MJ; Eaves AC
    Blood; 1997 Jul; 90(1):64-9. PubMed ID: 9207439
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficient long-term maintenance of chronic myeloid leukemic cobblestone area forming cells on a murine stromal cell line.
    Cornelissen JJ; Wognum AW; Ploemacher RE; Frassoni F; Wagemaker G; Hagemeijer A; Löwenberg B
    Leukemia; 1997 Jan; 11(1):126-33. PubMed ID: 9001428
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Leukotriene signaling via ALOX5 and cysteinyl leukotriene receptor 1 is dispensable for in vitro growth of CD34
    Dolinska M; Piccini A; Wong WM; Gelali E; Johansson AS; Klang J; Xiao P; Yektaei-Karin E; Strömberg UO; Mustjoki S; Stenke L; Ekblom M; Qian H
    Biochem Biophys Res Commun; 2017 Aug; 490(2):378-384. PubMed ID: 28623130
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modified in vitro conditions for cord blood-derived long-term culture-initiating cells.
    Podestà M; Piaggio G; Pitto A; Zocchi E; Soracco M; Frassoni F; Luchetti S; Painelli E; Bacigalupo A
    Exp Hematol; 2001 Mar; 29(3):309-14. PubMed ID: 11274758
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biomimetic macroporous PEG hydrogels as 3D scaffolds for the multiplication of human hematopoietic stem and progenitor cells.
    Raic A; Rödling L; Kalbacher H; Lee-Thedieck C
    Biomaterials; 2014 Jan; 35(3):929-40. PubMed ID: 24176196
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic myelogenous leukemia primitive hematopoietic progenitors demonstrate increased sensitivity to growth factor-induced proliferation and maturation.
    Bhatia R; Munthe HA; Williams AD; Zhang F; Forman SJ; Slovak ML
    Exp Hematol; 2000 Dec; 28(12):1401-12. PubMed ID: 11146162
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A clinically suitable ex vivo expansion culture system for LTC-IC and CFC using stroma-conditioned medium.
    Bhatia R; McGlave PB; Miller JS; Wissink S; Lin WN; Verfaillie CM
    Exp Hematol; 1997 Aug; 25(9):980-91. PubMed ID: 9257812
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hematopoiesis capacity, immunomodulatory effect and ex vivo expansion potential of mesenchymal stem cells are not impaired by cryopreservation.
    Zhao ZG; Li WM; Chen ZC; You Y; Zou P
    Cancer Invest; 2008 May; 26(4):391-400. PubMed ID: 18443960
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD34+CDw90(Thy-1)+ subset colocated with mesenchymal progenitors in human normal bone marrow hematon units is enriched in colony-forming unit megakaryocytes and long-term culture-initiating cells.
    Boiret N; Rapatel C; Boisgard S; Charrier S; Tchirkov A; Bresson C; Camilleri L; Berger J; Guillouard L; Guérin JJ; Pigeon P; Chassagne J; Berger MG
    Exp Hematol; 2003 Dec; 31(12):1275-83. PubMed ID: 14662335
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mesenchymal stem cells in patients with chronic myelogenous leukaemia or bi-phenotypic Ph+ acute leukaemia are not related to the leukaemic clone.
    Wöhrer S; Rabitsch W; Shehata M; Kondo R; Esterbauer H; Streubel B; Sillaber C; Raderer M; Jaeger U; Zielinski C; Valent P
    Anticancer Res; 2007; 27(6B):3837-41. PubMed ID: 18225540
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aryl hydrocarbon receptor (AHR) is a novel druggable pathway controlling malignant progenitor proliferation in chronic myeloid leukemia (CML).
    Gentil M; Hugues P; Desterke C; Telliam G; Sloma I; Souza LEB; Baykal S; Artus J; Griscelli F; Guerci A; Johnson-Ansah H; Foudi A; Bennaceur-Griscelli A; Turhan AG
    PLoS One; 2018; 13(8):e0200923. PubMed ID: 30091999
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of mesenchymal stem cells derived from bone marrow of children with oncohematological diseases on proliferation and self-renewal of hematopoietic progenitor cells in vitro.
    Isaikina Y; Shman T
    Exp Oncol; 2008 Jun; 30(2):121-8. PubMed ID: 18566575
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.